Literature DB >> 26300280

Impact of adult growth hormone deficiency on metabolic profile and cardiovascular risk [Review].

Lara Giovannini1, Giacomo Tirabassi, Giovanna Muscogiuri, Carolina Di Somma, Annamaria Colao, Giancarlo Balercia.   

Abstract

Adult growth hormone deficiency (GHD) is a well defined clinical condition, which is characterized by abnormal body composition, impaired physical activity and decreased quality of life. In addition, in recent years, growing interest has been shown towards cardiovascular risks in adult patients affected by GHD. In this regard, GHD is widely known to be associated with increased mortality, likely due to the increase of risk factors, such as central obesity, impaired lipid and glucose profiles and other less-known risk factors, such as inflammatory cytokines, endothelial dysfunction and oxidative stress. However, very few papers have recently discussed this topic. In this review, the aim is to clarify this issue by discussing evidence regarding the effects of adult GHD on metabolic and cardiovascular profiles.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26300280     DOI: 10.1507/endocrj.EJ15-0337

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  20 in total

1.  Cardiovascular risk in adult hypopituitaric patients with growth hormone deficiency: is there a role for vitamin D?

Authors:  Maria Cristina Savanelli; Elisabetta Scarano; Giovanna Muscogiuri; Luigi Barrea; Laura Vuolo; Manila Rubino; Silvia Savastano; Annamaria Colao; Carolina Di Somma
Journal:  Endocrine       Date:  2015-10-29       Impact factor: 3.633

2.  Oxidative stress in adult growth hormone deficiency: different plasma antioxidant patterns in comparison with metabolic syndrome.

Authors:  Antonio Mancini; Chantal Di Segni; Carmine Bruno; Giulio Olivieri; Francesco Guidi; Andrea Silvestrini; Elisabetta Meucci; Patrick Orlando; Sonia Silvestri; Luca Tiano; Alfredo Pontecorvi
Journal:  Endocrine       Date:  2017-11-15       Impact factor: 3.633

3.  Growth hormone deficiency and hypopituitarism in adults after complicated mild traumatic brain injury.

Authors:  Stefania Giuliano; Serafina Talarico; Lucia Bruno; Francesco Beniamino Nicoletti; Claudio Ceccotti; Antonino Belfiore
Journal:  Endocrine       Date:  2016-11-23       Impact factor: 3.633

Review 4.  Growth Hormone Therapy and Lipid Profile.

Authors:  Rajni Sharma
Journal:  Indian J Pediatr       Date:  2018-02-19       Impact factor: 1.967

5.  The visceral adiposity index is associated with insulin sensitivity and IGF-I levels in adults with growth hormone deficiency.

Authors:  Alessandro Ciresi; Stefano Radellini; Valentina Guarnotta; Carla Giordano
Journal:  Endocrine       Date:  2016-08-13       Impact factor: 3.633

6.  The Impact of Continuous Positive Airway Pressure on Circulating IGF-1 in Patients With Obstructive Sleep Apnea.

Authors:  Andreas Palm; Christian Berne; Helena Igelström; Pernilla Åsenlöf; Christer Janson; Eva Lindberg
Journal:  J Clin Sleep Med       Date:  2018-03-15       Impact factor: 4.062

Review 7.  Treatment of adult growth hormone deficiency with human recombinant growth hormone: an update on current evidence and critical review of advantages and pitfalls.

Authors:  Ana M Ramos-Leví; Mónica Marazuela
Journal:  Endocrine       Date:  2018-02-07       Impact factor: 3.633

8.  Association between Growth Differentiation Factor-15 and Risk of Cardiovascular Diseases in Patients with Adult Growth Hormone Deficiency.

Authors:  Xun Wu; Yunting Wang; Ziyu Ren; Linman Li; Wenjie Qian; Yue Chen; Wei Ren
Journal:  Int J Endocrinol       Date:  2021-08-06       Impact factor: 3.257

9.  A phase 2 trial of long-acting TransCon growth hormone in adult GH deficiency.

Authors:  Charlotte Höybye; Andreas F H Pfeiffer; Diego Ferone; Jens Sandahl Christiansen; David Gilfoyle; Eva Dam Christoffersen; Eva Mortensen; Jonathan A Leff; Michael Beckert
Journal:  Endocr Connect       Date:  2017-02-14       Impact factor: 3.335

10.  Correlation of Significantly Decreased Serum Circulating Mesencephalic Astrocyte-Derived Neurotrophic Factor Level With an Increased Risk of Future Cardiovascular Disease in Adult Patients With Growth Hormone Deficiency.

Authors:  Ziyu Ren; Yunting Wang; Qing Chen; Jiangchuan Long; Rui Zhang; Xun Wu; Wenjie Qian; Yue Chen; Dongfang Liu; Wei Ren
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-16       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.